Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Cancers Originate from Somatic Mutations in a Single Cell02:21

Cancers Originate from Somatic Mutations in a Single Cell

Cancer arises from mutations in the critical genes that allow healthy cells to escape cell cycle regulation and acquire the ability to proliferate indefinitely. Though originating from a single mutation event in one of the originator cells, cancer progresses when the mutant cell lines continue to gain more and more mutations, and finally, become malignant. For example, chronic myelogenous leukemia (CML) develops initially as a non-lethal increase in white blood cells, which progressively...
Tumor Progression02:07

Tumor Progression

Tumor progression is a phenomenon where the pre-formed tumor acquires successive mutations to become clinically more aggressive and malignant. In the 1950s, Foulds first described the stepwise progression of cancer cells through successive stages.
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
Adaptive Mechanisms in Cancer Cells02:53

Adaptive Mechanisms in Cancer Cells

Cancer cells accumulate genetic changes at an abnormally rapid rate due to the defects in the DNA repair mechanisms. From an evolutionary perspective, such genetic instability is advantageous for cancer development. Mutant cell lines accumulate a series of beneficial mutations that contribute to their progression into cancer.
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
What is Cancer?02:12

What is Cancer?

Cells and tissues must meticulously coordinate their activities for the normal functioning of the human body. Therefore, they exhibit socially responsible behavior - resting, growing, dividing, differentiating, or dying - for the organism’s benefit. Cancer arises when cells divide uncontrollably and invade other tissues or organs.
Although people have known about cancer for centuries, it was only in 1761 that Giovanni Morgagni of Padua performed a detailed autopsy of patients who died from...
Cancer02:18

Cancer

Cancers arise due to mutations in genes involved in the regulation of cell division, which leads to unrestricted cell proliferation. Modern science and medicine have made great strides in the understanding and treatment of cancer, including eradicating cancer in some patients. However, there is still no cure for cancer. This is largely due to the fact that cancer is a large group of many diseases.
Mouse Models of Cancer Study02:43

Mouse Models of Cancer Study

Mice have long served as models for studying human biology and pathology because of their phylogenetic and physiological similarity with humans. They are also easy to maintain and breed in the laboratory, and hence, many inbred strains are now available for research. Studies on mice have contributed immeasurably to our understanding of cancer biology.
The development of transgenic, knockout, and knock-in mice has led to an exponential increase in their use as model organisms in research,...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

An Intra-Body Power Transfer System via Localized Capacitive Coupling.

IEEE open journal of engineering in medicine and biology·2026
Same author

Symbiosis: Mutualism on the move.

Current biology : CB·2026
Same author

Characterisation and In Planta Activity of Bacteriophages That Infect the Key Bacterial Species Associated With Acute Oak Decline.

Microbial biotechnology·2026
Same author

Eco-evolutionary responses to plasmid-dependent phage constrain the spread of multidrug-resistance plasmids.

The ISME journal·2026
Same author

A model of polymicrobial catheter-associated urinary tract infection reveals biofilm-mediated modulation of treatment efficacy.

Journal of applied microbiology·2026
Same author

Genomic Surveillance of Epiphytic Pseudomonas syringae Highlights Shared Reservoirs and Cross-Habitat Threats to Cherry Orchards and Nearby Woodland Plants.

Molecular plant pathology·2026
Same journal

Incorporating Population Genomic Perspectives Into Kelp Conservation and Aquaculture in the Pacific Northwest.

Evolutionary applications·2026
Same journal

Multidisciplinary Evaluation of a 10-Year Restoration Program for Two Endangered Atlantic Salmon (<i>Salmo salar</i>) Populations.

Evolutionary applications·2026
Same journal

Tuberculosis Susceptibility and Inbreeding Depression Hinder <i>Ex Situ</i> Conservation in a Critically Endangered Rainforest Bird.

Evolutionary applications·2026
Same journal

Altitude-Associated Divergence of the Gut Microbiome in Endangered Forest Musk Deer: Evidence From Integrated Metagenomics, Metabolomics, and Culturomics.

Evolutionary applications·2026
Same journal

Evolutionary Footprint: A Systemic Indicator in Evolution, Ecology and Conservation.

Evolutionary applications·2026
Same journal

Integrating Ultimate and Proximate Explanations of Neurodivergence: Evolutionary Trade-Offs, Compensation, and Clinical Expression.

Evolutionary applications·2026
See all related articles

Related Experiment Video

Updated: May 10, 2026

Patient-Derived Tumor Explants As a "Live" Preclinical Platform for Predicting Drug Resistance in Patients
07:42

Patient-Derived Tumor Explants As a "Live" Preclinical Platform for Predicting Drug Resistance in Patients

Published on: February 7, 2021

First steps in experimental cancer evolution.

Tiffany B Taylor1, Louise J Johnson, Robert W Jackson

  • 1University of Reading, Whiteknights Reading, Berkshire.

Evolutionary Applications
|June 8, 2013
PubMed
Summary
This summary is machine-generated.

Applying experimental evolution to cancer research offers new insights into cancer progression and treatment. This approach observes cancer evolution in real-time, aiding understanding of drug resistance and tumor diversity.

Keywords:
carcinogenesisevolutionary trade-offskin competitionmetastasisresistanceresource competitionsocial evolution

More Related Videos

Orthotopic Injection of Breast Cancer Cells into the Mammary Fat Pad of Mice to Study Tumor Growth.
07:52

Orthotopic Injection of Breast Cancer Cells into the Mammary Fat Pad of Mice to Study Tumor Growth.

Published on: February 8, 2015

Generation of Heterogeneous Drug Gradients Across Cancer Populations on a Microfluidic Evolution Accelerator for Real-Time Observation
10:24

Generation of Heterogeneous Drug Gradients Across Cancer Populations on a Microfluidic Evolution Accelerator for Real-Time Observation

Published on: September 19, 2019

Related Experiment Videos

Last Updated: May 10, 2026

Patient-Derived Tumor Explants As a "Live" Preclinical Platform for Predicting Drug Resistance in Patients
07:42

Patient-Derived Tumor Explants As a "Live" Preclinical Platform for Predicting Drug Resistance in Patients

Published on: February 7, 2021

Orthotopic Injection of Breast Cancer Cells into the Mammary Fat Pad of Mice to Study Tumor Growth.
07:52

Orthotopic Injection of Breast Cancer Cells into the Mammary Fat Pad of Mice to Study Tumor Growth.

Published on: February 8, 2015

Generation of Heterogeneous Drug Gradients Across Cancer Populations on a Microfluidic Evolution Accelerator for Real-Time Observation
10:24

Generation of Heterogeneous Drug Gradients Across Cancer Populations on a Microfluidic Evolution Accelerator for Real-Time Observation

Published on: September 19, 2019

Area of Science:

  • Evolutionary biology
  • Cancer research
  • Experimental evolution

Background:

  • Cancer development, progression, and treatment response are influenced by evolutionary processes.
  • Harnessing evolutionary theory is crucial for understanding cancer's clinical progression.
  • Developing experimental systems to test cancer evolution theories is a key challenge.

Purpose of the Study:

  • To propose and justify the application of experimental evolution to cancer research.
  • To demonstrate the feasibility and potential insights of experimental cancer evolution.
  • To identify key areas in cancer biology amenable to this approach.

Main Methods:

  • Adapting the experimental evolution approach, typically used for microorganisms, to cancer research.
  • Utilizing cell cultures with traits similar to microorganisms for evolutionary studies.
  • Observing cancer evolution in real-time to analyze ecological selection causes and genetic changes.

Main Results:

  • Experimental cancer evolution is feasible and can provide significant insights into cancer traits.
  • This approach allows for disentangling ecological causes of natural selection in cancer.
  • It enables identification of the genetic basis and repeatability of evolutionary changes in cancer.

Conclusions:

  • Experimental evolution offers a powerful framework for studying cancer biology.
  • It can illuminate selective pressures driving the evolution of clinically significant cancer traits.
  • This approach can guide future research in cancer treatment and drug development, focusing on drug resistance, social evolution, and resource competition.